Fail-safe program for new medical technology focuses on patient safety
New medical technology offers the promise of improving patient care, as well as the potential for harm if caregivers are not sufficiently educated about its operation and use.
Without a comprehensive approach, caregivers may learn how to use complex technology at the patient’s bedside, through trial and error, instruction manuals or informally from their colleagues.
An article in AACN Advanced Critical Care describes how Memorial Hermann Health System in Houston developed an interdisciplinary fail-safe process to analyze and scale training for use of medical devices, with a risk assessment tool to predict the severity and frequency of potential harm to patients. The journal article, “Optimizing Fail-Safe Use of Complex Medical Devices,” describes the key factors that contribute to adverse patient safety events and the principles underlying high-reliability organizations.
After a device is evaluated and approved for purchase, the process assesses potential risks, identifies varying levels of required education and training, and mandates competency reporting. Integrating new technology into patient care requires that clinical staff be competent in the operation of all approved new and updated medical devices.
One of the largest not-for-profit health systems in southeast Texas, Memorial Hermann has 14 hospitals of its own, five others operated through joint ventures and numerous specialty programs and services throughout the Greater Houston area. From 2012 through 2018, more than 100 medical devices have gone through its fail-safe assessment, with 46% receiving the highest level of scrutiny and education due to the risk assessment.
The article includes the tools and worksheets used by Memorial Hermann staff for each phase of the process, from initial device request through compliance tracking and reporting. Four case scenarios summarize how the fail-safe review was applied to different clinical situations and review the outcomes of the education required before rollout of the device.
Memorial Hermann’s fail-safe process is designed to eliminate human error during medical device use through standardized and evidence-based education and training. Before a medical device is approved for patient care or even enters the fail-safe process, it undergoes an in-depth evaluation led by the supply chain department. The evaluation includes a cost-analysis review, trial use and feedback from stakeholders and end-users. Medical devices that qualify for fail-safe assessment can be new devices, those with new functionality or updates, or substitute or replacement technology.
Access the issue by visiting the AACN Advanced Critical Care website at http://acc.aacnjournals.org/.